Search Results

Displaying Results 801-825 of 910 "'FAT'"

Oct 27, 2025, 07:49 ET Hoth Therapeutics Launches VA-Backed Study of Novel GDNF Weight Loss Therapy Targeting Obesity and Fatty Liver Disease

with key milestones as follows: October 2025 – Initiate high-fat and control diet groups December 2025 – Begin GDNF and comparator dosing

More news about: Hoth Therapeutics, Inc.


Oct 26, 2025, 20:00 ET Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3

improve hepatic fat metabolism through the activation of glucagon receptor. Mazdutide has demonstrated excellent weight loss and glucose-lowering effects in clinical studies, as well as reducing waist circumference, blood lipids, blood pressure, serum uric acid, liver enzymes, liver fat content and improved

More news about: Innovent Biologics


Oct 23, 2025, 08:04 ET From Quick Fix to Real Change: L-Nutra Launches the Prolon® Guided Health Program for Weight and Metabolic Wellness

L-Nutra's leadership in medical nutrition - uniting patented nutrition technology with clinician-guided expertise to help individuals achieve sustainable fat-focused weight loss, protect lean muscle, and improve long-term metabolic and heart health.

More news about: L-Nutra Inc.


Oct 23, 2025, 08:00 ET Vial Initiates Phase 1 Trial of VIAL-INHBE, an INHBE (Activin E) siRNA for the Treatment of Obesity

indications with a projected Q6M dosing interval VIAL-INHBE DIO mouse model data demonstrated compelling fat-selective weight-loss and lean mass preservation Combination therapy with a low-dose GLP-1

More news about: Vial


Oct 22, 2025, 19:02 ET Innovations Stem Cell Center Named "Top Stem Cell Therapy Treatments Company 2025" by Life Sciences Review

Featured on the cover of Life Sciences Review, Dr. Bill Johnson, CEO of Innovations Stem Cell Center, shared how ISCC's unique focus on fat-derived (adipose) stem cells and consistent clinical protocols have established a new benchmark for safety, reproducibility, and success in the field.

More news about: iMedstem LLC DBA Innovations Stem Cell Center


Oct 22, 2025, 18:06 ET Innovations Stem Cell Center Named "Top Stem Cell Therapy Treatments Company 2025" by Life Sciences Review

Featured on the cover of Life Sciences Review, Dr. Bill Johnson, CEO of Innovations Stem Cell Center, shared how ISCC's unique focus on fat-derived (adipose) stem cells and consistent clinical protocols have established a new benchmark for safety, reproducibility, and success in the field.

More news about: iMedstem LLC DBA Innovations Stem Cell Center


Oct 22, 2025, 16:05 ET Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

non-alcoholic fatty liver disease (NAFLD) and elevated LDL-C, patients who received VK2809 demonstrated statistically significant reductions in LDL-C and liver fat content compared with patients who received placebo. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin

More news about: Viking Therapeutics, Inc.


Oct 22, 2025, 15:19 ET Food Additives Market to Reach USD 183.51 billion by 2032, Growing At An 5.4% CAGR - Credence Research

specialized additives. This includes the development of allergen-free emulsifiers and binders, gluten-free texturizers for baked goods, and fat replacers for low-fat formulations. For example, Ingredion Incorporated launched a new line of fava bean-based functional proteins in late 2024, which were marketed

More news about: Credence Research Inc.


Oct 22, 2025, 09:00 ET Quest Nutrition Expands Its Lineup with Protein Donuts

QuestNutrition.com. *Per serving. See Nutrition Facts for Calories and Saturated Fat Contents. 11g of Total Fat. Net Carbs = Totals Carbs – Fiber – Sugar Alcohols. <1g Sugar, Including 0g added sugars per serving. Not a low-calorie food

More news about: Simply Good Foods Co.


Oct 21, 2025, 16:01 ET Can Ozempic Slow Aging? New Study Raises Hope

Beyond Weight Loss: Analysis controlled for BMI, indicating benefits beyond semaglutide's known effect of visceral fat reduction. Predictive Insights: The DNA methylation tests donated by TruDiagnostic offers predictive

More news about: TruDiagnostic


Oct 21, 2025, 11:44 ET Steller Wellness Offering New Brain Stimulation Technology to Optimize Mental Health

Emsculpt Neo, a treatment using muscle activation and heat to burn up to 30% fat and build up to 25% muscle in hard-to-treat areas. For those dealing with incontinence, Steller Wellness offers the EMSELLA chair,

More news about: Steller Wellness


Oct 21, 2025, 11:00 ET RunStar® Expands Smart Scale Lineup With Three New Models Designed for Personalized Health Tracking

Weight trend tracking, so that users can view their weight over time and get a fuller picture of their healthBody fat, including a breakdown of subcutaneous versus visceral fatMuscle mass, showing how much of the body's weight comes from muscleBMI, providing a general indicator

More news about: RunStar


Oct 21, 2025, 08:51 ET JYM Supplement Science and Jordan's House Unite to Fuel Fitness and Support Special Needs Families

mixed as a powder or in capsule form. The results are what you see in the mirror, feel in the gym, and experience in everyday life: more muscle, less fat, greater strength, and improved health, confidence, and performance. The science behind every JYM product is based on decades of research by Dr. Jim

More news about: JYM Supplement Science


Oct 21, 2025, 07:05 ET Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity

non-alcoholic fatty liver disease (NAFLD) and elevated LDL-C, patients who received VK2809 demonstrated statistically significant reductions in LDL-C and liver fat content compared with patients who received placebo. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin

More news about: Viking Therapeutics, Inc.


Oct 21, 2025, 03:00 ET MATR Foods completes €40m fundraise to scale-up production and internationalise sales of its organic plant-based meat alternatives

The company's flagship product, MATR Fungi Mince, is made entirely from natural ingredients grown in Scandinavia. Rich in protein and fibre and low in fat, the product has an amino acid profile like meat, but with a carbon footprint of just 1.5 kg CO2e per kg, which is 94% lower than that of

More news about: MATR Foods


Oct 20, 2025, 11:48 ET New Study from The Farmer's Dog Reveals Fresh, Human-Grade Dog Food Can Promote Healthier Aging in Senior Dogs

eicosapentaenoate (EPA), docosapentaenoate (DPA), and docosahexaenoate (DHA). Serum 3-hydroxybutyrate (BHBA), a ketone body, rose reflecting enhanced fat utilization and healthy ketosis. Reduced fatty acid synthesis: Malonate, a marker of fatty acid

More news about: The Farmer's Dog


Oct 20, 2025, 10:45 ET Pulse Ingredients Market is expected to generate a revenue of USD 32.05 Billion by 2031, Globally, at 6% CAGR: Verified Market Research®

pulses such as peas, chickpeas, and lentils. These ingredients offer superior nutrition profiles—high protein, fiber, and low-fat content—making them ideal for bakery, snacks, and meat substitutes. Leading food brands are reformulating products with pulse

More news about: Verified Market Research


Oct 20, 2025, 08:47 ET L-Nutra Recognized by Shortlister as a Q4 Top Vendor in Both Corporate Weight Management and Diabetes Management Programs

67% reduction in medication use 22 lbs average fat-focused weight loss with muscle protection 1.4% average A1C reduction

More news about: L-Nutra Inc.


Oct 20, 2025, 08:00 ET RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor

include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. Hepatitis B infection in carriers of the virus. Symptoms include muscle aches, feeling

More news about: AbbVie


Oct 20, 2025, 07:30 ET Endo Launches First and Only Generic Version of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in the United States

the small intestine, separating the active moiety, phenylbutyrate, from glycerol. Low or absent pancreatic enzymes or intestinal disease resulting in fat malabsorption may result in reduced or absent digestion of glycerol phenylbutyrate and/or absorption of phenylbutyrate and reduced control of plasma

More news about: Endo USA, Inc.


Oct 16, 2025, 15:33 ET Chiquita Brings Immersive Brand Experiences and Innovation to IFPA 2025

farming, biodiversity and giving back to the communities in which the banana plantations operate. Great-tasting and convenient Chiquita bananas are fat-free, and provide a source of potassium, fiber and vitamin B6. To learn more, visit 

More news about: Chiquita Brands International, Inc.


Oct 16, 2025, 11:32 ET A NEW ERA OF HEAT: TACO BELL® LAUNCHES FLAMIN' HOT® GRILLED CHEESE BURRITO

The all new Flamin' Hot® Rice is joined by nacho cheese sauce, seasoned beef, creamy chipotle sauce, Fritos® Flamin Hot'® chips, reduced fat sour cream, three-cheese blend, and a layer of melty grilled cheese on the outside for a boldly cheesy, spicy, crunchy bite.

More news about: Taco Bell Corp.


Oct 16, 2025, 08:00 ET Beyond GLP-1s: Withings Health Solutions Unveils Best Practices for Obesity Care Management Programs

settings. Yazen, a European digital obesity care platform, uses Withings body composition scales to distinguish fat vs. muscle loss, track visceral fat, and intervene early. This gives clinicians clearer, real-time insights to support safe, evidence-based treatment adjustments and set

More news about: Withings Health Solutions


Oct 15, 2025, 16:05 ET Viking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025

non-alcoholic fatty liver disease (NAFLD) and elevated LDL-C, patients who received VK2809 demonstrated statistically significant reductions in LDL-C and liver fat content compared with patients who received placebo. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin

More news about: Viking Therapeutics, Inc.


Oct 15, 2025, 09:00 ET What's Making Waves in Toy Aisles? The Toy Insider™ Experts Reveal Top Holiday Trends Taking Over Toy Boxes in 2025

(Chompshop), Decora Dream (Cepia), Hello Blink Tattoo Maker (Ceaco), MAGNA-Tiles Rail Racers Deluxe 90-Piece Set (MAGNA-Tiles), Magshuto Stunt Park (Fat Brain Toys), My Robotic Pet: Coding Chameleon (Thames & Kosmos), Play-Doh Barbie Designer Fashion Show Playset (Hasbro), RoseArt Crystal Gem Creations

More news about: The Toy Insider


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.